Effrx Pharmaceuticals SA, of Freienbach, Switzerland, appointed Lorraine Zakin director, medical affairs, Peter Lichtlen chief medical advisor, Christiane Sievert director, regulatory affairs and Victor Papavasileiou vice president, business development.